4-butyrolactone has been researched along with Adverse Drug Event in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dargan, PI; Dines, AM; Erik Hovda, K; Eyer, F; Geith, S; Giraudon, I; Heier, EC; Heyerdahl, F; Liechti, ME; Miró, Ò; Rabe, C; Vallersnes, OM; Wood, DM; Yates, C; Zellner, T | 1 |
| Geum, M; Kim, HJ; Ko, HY; Na, YJ | 1 |
2 other study(ies) available for 4-butyrolactone and Adverse Drug Event
| Article | Year |
|---|---|
Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs.
Topics: 4-Butyrolactone; Alcohol Drinking; Drug-Related Side Effects and Adverse Reactions; Ethanol; Humans; Illicit Drugs; Sodium Oxybate | 2022 |
Cutaneous adverse drug reaction in a dog following firocoxib treatment.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dog Diseases; Dogs; Drug-Related Side Effects and Adverse Reactions; Female; Sulfones | 2021 |